Cell And Gene Therapy Manufacturing Market By Therapy Type (Cell therapy, Gene therapy) By Mode (In-house Manufacturing, Contract Manufacturing (CDMOs & CMOs)) By Scale (Preclinical and Clinical-Scale, Commercial-Scale) By Application (Oncology (Cancer Treatment), Neurological Disorders, Cardiovascular Diseases, Rare & Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications) By End-user (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations (CDMOs/CMOs), Research Institutes & Academic Organizations, Hospitals & Clinics) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Cell and Gene Therapy Manufacturing Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of Cell and Gene Therapy Manufacturing Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Cell and Gene Therapy Manufacturing Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Type, 2020-2034
  • 3.3. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
    • 3.3.1. Cell therapy
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Gene therapy
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
  • 3.4. Global Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Mode, 2020-2034
  • 3.5. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
    • 3.5.1. In-house Manufacturing
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Contract Manufacturing (CDMOs & CMOs)
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
  • 3.6. Global Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale, 2020-2034
  • 3.7. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
    • 3.7.1. Preclinical and Clinical-Scale
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Commercial-Scale
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
  • 3.8. Global Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 3.9. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
    • 3.9.1. Oncology
      • 3.9.1.1. Insights
      • 3.9.1.2. Key Takeaways
    • 3.9.2. Neurological Disorders
      • 3.9.2.1. Insights
      • 3.9.2.2. Key Takeaways
    • 3.9.3. Cardiovascular Diseases
      • 3.9.3.1. Insights
      • 3.9.3.2. Key Takeaways
    • 3.9.4. Rare & Genetic Disorders
      • 3.9.4.1. Insights
      • 3.9.4.2. Key Takeaways
    • 3.9.5. Infectious Diseases
      • 3.9.5.1. Insights
      • 3.9.5.2. Key Takeaways
    • 3.9.6. Musculoskeletal Disorders
      • 3.9.6.1. Insights
      • 3.9.6.2. Key Takeaways
    • 3.9.7. Autoimmune Diseases
      • 3.9.7.1. Insights
      • 3.9.7.2. Key Takeaways
    • 3.9.8. Other Applications
      • 3.9.8.1. Insights
      • 3.9.8.2. Key Takeaways
  • 3.10. Global Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 3.11. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
    • 3.11.1. Pharmaceutical & Biotechnology Companies
      • 3.11.1.1. Insights
      • 3.11.1.2. Key Takeaways
    • 3.11.2. Contract Development & Manufacturing Organizations (CDMOs/CMOs)
      • 3.11.2.1. Insights
      • 3.11.2.2. Key Takeaways
    • 3.11.3. Research Institutes & Academic Organizations
      • 3.11.3.1. Insights
      • 3.11.3.2. Key Takeaways
    • 3.11.4. Hospitals & Clinics
      • 3.11.4.1. Insights
      • 3.11.4.2. Key Takeaways
• 4. Global Cell and Gene Therapy Manufacturing Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Region
• 5. North America Cell and Gene Therapy Manufacturing Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Type, 2020-2034
  • 5.3. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
  • 5.4. North America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Mode, 2020-2034
  • 5.5. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
  • 5.6. North America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale, 2020-2034
  • 5.7. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
  • 5.8. North America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 5.9. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
  • 5.10. North America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 5.11. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
  • 5.12. North America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.13. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country
    • 5.13.1. The US
    • 5.13.2. Canada
• 6. Europe Cell and Gene Therapy Manufacturing Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Type, 2020-2034
  • 6.3. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
  • 6.4. Europe Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Mode, 2020-2034
  • 6.5. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
  • 6.6. Europe Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale, 2020-2034
  • 6.7. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
  • 6.8. Europe Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 6.9. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
  • 6.10. Europe Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 6.11. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
  • 6.12. Europe Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.13. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country
    • 6.13.1. Germany
    • 6.13.2. The UK
    • 6.13.3. France
    • 6.13.4. Spain
    • 6.13.5. Italy
    • 6.13.6. Russia
    • 6.13.7. Netherland
    • 6.13.8. Rest of Europe
• 7. Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Type, 2020-2034
  • 7.3. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
  • 7.4. Asia Pacific Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Mode, 2020-2034
  • 7.5. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
  • 7.6. Asia Pacific Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale, 2020-2034
  • 7.7. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
  • 7.8. Asia Pacific Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 7.9. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
  • 7.10. Asia Pacific Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 7.11. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
  • 7.12. Asia Pacific Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.13. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country
    • 7.13.1. China
    • 7.13.2. Japan
    • 7.13.3. South Korea
    • 7.13.4. India
    • 7.13.5. Australia
    • 7.13.6. New Zealand
    • 7.13.7. Singapore
    • 7.13.8. Thailand
    • 7.13.9. Vietnam
    • 7.13.10. Rest of Asia Pacific
• 8. Latin America Cell and Gene Therapy Manufacturing Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Type, 2020-2034
  • 8.3. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
  • 8.4. Latin America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Mode, 2020-2034
  • 8.5. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
  • 8.6. Latin America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale, 2020-2034
  • 8.7. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
  • 8.8. Latin America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 8.9. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
  • 8.10. Latin America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 8.11. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
  • 8.12. Latin America Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.13. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country
    • 8.13.1. Brazil
    • 8.13.2. Mexico
    • 8.13.3. Rest of Latin America
• 9. Middle East & Africa Cell and Gene Therapy Manufacturing Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Therapy Type, 2020-2034
  • 9.3. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
  • 9.4. Middle East & Africa Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Mode, 2020-2034
  • 9.5. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
  • 9.6. Middle East & Africa Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale, 2020-2034
  • 9.7. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
  • 9.8. Middle East & Africa Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 9.9. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
  • 9.10. Middle East & Africa Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-User, 2020-2034
  • 9.11. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
  • 9.12. Middle East & Africa Cell and Gene Therapy Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.13. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country
    • 9.13.1. South Africa
    • 9.13.2. Saudi Arabia
    • 9.13.3. UAE
    • 9.13.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
    • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Lonza
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. Bluebird Bio Inc.
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Catalent Inc.
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. F. Hoffmann-La Roche Ltd.
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. Samsung Biologics
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. Boehringer Ingelheim
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. Cellular Therapeutics
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Hitachi Chemical Co., Ltd.
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
    • 10.7.9. Bluebird Bio Inc.
      • 10.7.9.1. Company Details
      • 10.7.9.2. Business Overview
      • 10.7.9.3. Product Portfolio
      • 10.7.9.4. Financial Insights
      • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.9.6. SWOT Analysis
      • 10.7.9.7. Geographic Footprint
    • 10.7.10. Takara Bio Inc.
      • 10.7.10.1. Company Details
      • 10.7.10.2. Business Overview
      • 10.7.10.3. Product Portfolio
      • 10.7.10.4. Financial Insights
      • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.10.6. SWOT Analysis
      • 10.7.10.7. Geographic Footprint
    • 10.7.11. Miltenyi Biotec
      • 10.7.11.1. Company Details
      • 10.7.11.2. Business Overview
      • 10.7.11.3. Product Portfolio
      • 10.7.11.4. Financial Insights
      • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.11.6. SWOT Analysis
      • 10.7.11.7. Geographic Footprint
    • 10.7.12. Thermo Fisher Scientific
      • 10.7.12.1. Company Details
      • 10.7.12.2. Business Overview
      • 10.7.12.3. Product Portfolio
      • 10.7.12.4. Financial Insights
      • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.12.6. SWOT Analysis
      • 10.7.12.7. Geographic Footprint
    • 10.7.13. F. Hoffmann-La Roche Ltd
      • 10.7.13.1. Company Details
      • 10.7.13.2. Business Overview
      • 10.7.13.3. Product Portfolio
      • 10.7.13.4. Financial Insights
      • 10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.13.6. SWOT Analysis
      • 10.7.13.7. Geographic Footprint
    • 10.7.14. Novartis AG
      • 10.7.14.1. Company Details
      • 10.7.14.2. Business Overview
      • 10.7.14.3. Product Portfolio
      • 10.7.14.4. Financial Insights
      • 10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.14.6. SWOT Analysis
      • 10.7.14.7. Geographic Footprint
    • 10.7.15. Merck KGaA
      • 10.7.15.1. Company Details
      • 10.7.15.2. Business Overview
      • 10.7.15.3. Product Portfolio
      • 10.7.15.4. Financial Insights
      • 10.7.15.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.15.6. SWOT Analysis
      • 10.7.15.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 2. Global Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 3. Global Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 4. Global Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 5. Global Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 6. Global Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Region, 2020-2034
• Table 7. North America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 8. North America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 9. North America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 10. North America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 11. North America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 12. North America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Country, 2020-2034
• Table 13. The US Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 14. The US Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 15. The US Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 16. The US Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 17. The US Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 18. Canada Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 19. Canada Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 20. Canada Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 21. Canada Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 22. Canada Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 23. Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 24. Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 25. Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 26. Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 27. Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 28. Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Country, 2020-2034
• Table 29. Germany Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 30. Germany Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 31. Germany Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 32. Germany Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 33. Germany Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 34. The UK Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 35. The UK Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 36. The UK Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 37. The UK Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 38. The UK Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 39. France Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 40. France Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 41. France Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 42. France Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 43. France Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 44. Spain Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 45. Spain Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 46. Spain Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 47. Spain Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 48. Spain Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 49. Italy Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 50. Italy Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 51. Italy Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 52. Italy Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 53. Italy Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 54. Russia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 55. Russia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 56. Russia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 57. Russia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 58. Russia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 59. Netherland Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 60. Netherland Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 61. Netherland Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 62. Netherland Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 63. Netherland Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 64. Rest of Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 65. Rest of Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 66. Rest of Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 67. Rest of Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 68. Rest of Europe Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 69. Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 70. Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 71. Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 72. Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 73. Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 74. Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Country, 2020-2034
• Table 75. China Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 76. China Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 77. China Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 78. China Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 79. China Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 80. India Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 81. India Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 82. India Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 83. India Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 84. India Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 85. Japan Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 86. Japan Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 87. Japan Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 88. Japan Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 89. Japan Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 90. South Korea Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 91. South Korea Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 92. South Korea Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 93. South Korea Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 94. South Korea Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 95. Australia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 96. Australia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 97. Australia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 98. Australia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 99. Australia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 100. New Zealand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 101. New Zealand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 102. New Zealand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 103. New Zealand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 104. New Zealand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 105. Singapore Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 106. Singapore Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 107. Singapore Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 108. Singapore Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 109. Singapore Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 110. Thailand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 111. Thailand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 112. Thailand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 113. Thailand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 114. Thailand Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 115. Vietnam Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 116. Vietnam Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 117. Vietnam Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 118. Vietnam Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 119. Vietnam Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 120. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 121. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 122. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 123. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 124. Rest of Asia Pacific Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 125. Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 126. Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 127. Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 128. Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 129. Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 130. Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Country, 2020-2034
• Table 131. Brazil Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 132. Brazil Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 133. Brazil Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 134. Brazil Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 135. Brazil Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 136. Mexico Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 137. Mexico Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 138. Mexico Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 139. Mexico Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 140. Mexico Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 141. Rest of Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 142. Rest of Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 143. Rest of Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 144. Rest of Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 145. Rest of Latin America Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 146. Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 147. Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 148. Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 149. Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 150. Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 151. Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Country, 2020-2034
• Table 152. South Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 153. South Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 154. South Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 155. South Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 156. South Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 157. Saudi Arabia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 158. Saudi Arabia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 159. Saudi Arabia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 160. Saudi Arabia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 161. Saudi Arabia Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 162. UAE Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 163. UAE Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 164. UAE Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 165. UAE Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 166. UAE Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034
• Table 167. Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Therapy Type, 2020-2034
• Table 168. Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Mode, 2020-2034
• Table 169. Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Scale, 2020-2034
• Table 170. Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By Application, 2020-2034
• Table 171. Rest of Middle East & Africa Cell and Gene Therapy Manufacturing Market Value (US$ Mn), By End-User, 2020-2034

List of Figures

• Figure 1. Global Cell and Gene Therapy Manufacturing Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Cell and Gene Therapy Manufacturing Market
• Figure 5. Global Cell and Gene Therapy Manufacturing Market Analysis, By Therapy Type, 2020, 2024 and 2034
• Figure 6. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
• Figure 7. Global Cell and Gene Therapy Manufacturing Market Analysis, By Mode, 2020, 2024 and 2034
• Figure 8. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
• Figure 9. Global Cell and Gene Therapy Manufacturing Market Analysis, By Scale, 2020, 2024 and 2034
• Figure 10. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
• Figure 11. Global Cell and Gene Therapy Manufacturing Market Analysis, By Application, 2020, 2024 and 2034
• Figure 12. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
• Figure 13. Global Cell and Gene Therapy Manufacturing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 14. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
• Figure 15. Global Cell and Gene Therapy Manufacturing Market Analysis, By Region, 2020, 2024 and 2034
• Figure 16. Global Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Region
• Figure 17. North America Cell and Gene Therapy Manufacturing Market Analysis, By Therapy Type, 2020, 2024 and 2034
• Figure 18. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
• Figure 19. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cell therapy, 2020-2034
• Figure 20. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Gene therapy, 2020-2034
• Figure 21. North America Cell and Gene Therapy Manufacturing Market Analysis, By Mode, 2020, 2024 and 2034
• Figure 22. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
• Figure 23. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by In-house Manufacturing, 2020-2034
• Figure 24. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Manufacturing (CDMOs & CMOs), 2020-2034
• Figure 25. North America Cell and Gene Therapy Manufacturing Market Analysis, By Scale, 2020, 2024 and 2034
• Figure 26. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
• Figure 27. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Preclinical and Clinical-Scale, 2020-2034
• Figure 28. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Commercial-Scale, 2020-2034
• Figure 29. North America Cell and Gene Therapy Manufacturing Market Analysis, By Application, 2020, 2024 and 2034
• Figure 30. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
• Figure 31. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Oncology, 2020-2034
• Figure 32. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 33. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 34. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Rare & Genetic Disorders, 2020-2034
• Figure 35. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 36. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Musculoskeletal Disorders, 2020-2034
• Figure 37. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Autoimmune Diseases, 2020-2034
• Figure 38. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Other Applications, 2020-2034
• Figure 39. North America Cell and Gene Therapy Manufacturing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 40. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
• Figure 41. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 42. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Development & Manufacturing Organizations (CDMOs/CMOs), 2020-2034
• Figure 43. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Research Institutes & Academic Organizations, 2020-2034
• Figure 44. North America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Hospitals & Clinics, 2020-2034
• Figure 45. North America Cell and Gene Therapy Manufacturing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 46. North America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country
• Figure 47. Europe Cell and Gene Therapy Manufacturing Market Analysis, By Therapy Type, 2020, 2024 and 2034
• Figure 48. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
• Figure 49. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cell therapy, 2020-2034
• Figure 50. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Gene therapy, 2020-2034
• Figure 51. Europe Cell and Gene Therapy Manufacturing Market Analysis, By Mode, 2020, 2024 and 2034
• Figure 52. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
• Figure 53. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by In-house Manufacturing, 2020-2034
• Figure 54. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Manufacturing (CDMOs & CMOs), 2020-2034
• Figure 55. Europe Cell and Gene Therapy Manufacturing Market Analysis, By Scale, 2020, 2024 and 2034
• Figure 56. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
• Figure 57. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Preclinical and Clinical-Scale, 2020-2034
• Figure 58. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Commercial-Scale, 2020-2034
• Figure 59. Europe Cell and Gene Therapy Manufacturing Market Analysis, By Application, 2020, 2024 and 2034
• Figure 60. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
• Figure 61. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Oncology, 2020-2034
• Figure 62. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 63. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 64. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Rare & Genetic Disorders, 2020-2034
• Figure 65. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 66. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Musculoskeletal Disorders, 2020-2034
• Figure 67. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Autoimmune Diseases, 2020-2034
• Figure 68. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Other Applications, 2020-2034
• Figure 69. Europe Cell and Gene Therapy Manufacturing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 70. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
• Figure 71. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 72. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Development & Manufacturing Organizations (CDMOs/CMOs), 2020-2034
• Figure 73. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Research Institutes & Academic Organizations, 2020-2034
• Figure 74. Europe Cell and Gene Therapy Manufacturing Market (US$ Mn), by Hospitals & Clinics, 2020-2034
• Figure 75. Europe Cell and Gene Therapy Manufacturing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 76. Europe Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country
• Figure 77. Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis, By Therapy Type, 2020, 2024 and 2034
• Figure 78. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
• Figure 79. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cell therapy, 2020-2034
• Figure 80. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Gene therapy, 2020-2034
• Figure 81. Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis, By Mode, 2020, 2024 and 2034
• Figure 82. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
• Figure 83. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by In-house Manufacturing, 2020-2034
• Figure 84. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Manufacturing (CDMOs & CMOs), 2020-2034
• Figure 85. Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis, By Scale, 2020, 2024 and 2034
• Figure 86. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
• Figure 87. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Preclinical and Clinical-Scale, 2020-2034
• Figure 88. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Commercial-Scale, 2020-2034
• Figure 89. Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis, By Application, 2020, 2024 and 2034
• Figure 90. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
• Figure 91. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Oncology, 2020-2034
• Figure 92. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 93. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 94. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Rare & Genetic Disorders, 2020-2034
• Figure 95. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 96. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Musculoskeletal Disorders, 2020-2034
• Figure 97. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Autoimmune Diseases, 2020-2034
• Figure 98. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Other Applications, 2020-2034
• Figure 99. Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 100. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
• Figure 101. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 102. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Development & Manufacturing Organizations (CDMOs/CMOs), 2020-2034
• Figure 103. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Research Institutes & Academic Organizations, 2020-2034
• Figure 104. Asia Pacific Cell and Gene Therapy Manufacturing Market (US$ Mn), by Hospitals & Clinics, 2020-2034
• Figure 105. Asia Pacific Cell and Gene Therapy Manufacturing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 106. Asia Pacific Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country
• Figure 107. Latin America Cell and Gene Therapy Manufacturing Market Analysis, By Therapy Type, 2020, 2024 and 2034
• Figure 108. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
• Figure 109. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cell therapy, 2020-2034
• Figure 110. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Gene therapy, 2020-2034
• Figure 111. Latin America Cell and Gene Therapy Manufacturing Market Analysis, By Mode, 2020, 2024 and 2034
• Figure 112. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
• Figure 113. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by In-house Manufacturing, 2020-2034
• Figure 114. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Manufacturing (CDMOs & CMOs), 2020-2034
• Figure 115. Latin America Cell and Gene Therapy Manufacturing Market Analysis, By Scale, 2020, 2024 and 2034
• Figure 116. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
• Figure 117. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Preclinical and Clinical-Scale, 2020-2034
• Figure 118. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Commercial-Scale, 2020-2034
• Figure 119. Latin America Cell and Gene Therapy Manufacturing Market Analysis, By Application, 2020, 2024 and 2034
• Figure 120. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
• Figure 121. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Oncology, 2020-2034
• Figure 122. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 123. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 124. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Rare & Genetic Disorders, 2020-2034
• Figure 125. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 126. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Musculoskeletal Disorders, 2020-2034
• Figure 127. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Autoimmune Diseases, 2020-2034
• Figure 128. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Other Applications, 2020-2034
• Figure 129. Latin America Cell and Gene Therapy Manufacturing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 130. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
• Figure 131. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 132. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Development & Manufacturing Organizations (CDMOs/CMOs), 2020-2034
• Figure 133. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Research Institutes & Academic Organizations, 2020-2034
• Figure 134. Latin America Cell and Gene Therapy Manufacturing Market (US$ Mn), by Hospitals & Clinics, 2020-2034
• Figure 135. Latin America Cell and Gene Therapy Manufacturing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 136. Latin America Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country
• Figure 137. Middle East & Africa Cell and Gene Therapy Manufacturing Market Analysis, By Therapy Type, 2020, 2024 and 2034
• Figure 138. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Therapy Type
• Figure 139. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cell therapy, 2020-2034
• Figure 140. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Gene therapy, 2020-2034
• Figure 141. Middle East & Africa Cell and Gene Therapy Manufacturing Market Analysis, By Mode, 2020, 2024 and 2034
• Figure 142. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Mode
• Figure 143. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by In-house Manufacturing, 2020-2034
• Figure 144. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Manufacturing (CDMOs & CMOs), 2020-2034
• Figure 145. Middle East & Africa Cell and Gene Therapy Manufacturing Market Analysis, By Scale, 2020, 2024 and 2034
• Figure 146. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Scale
• Figure 147. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Preclinical and Clinical-Scale, 2020-2034
• Figure 148. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Commercial-Scale, 2020-2034
• Figure 149. Middle East & Africa Cell and Gene Therapy Manufacturing Market Analysis, By Application, 2020, 2024 and 2034
• Figure 150. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Application
• Figure 151. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Oncology, 2020-2034
• Figure 152. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Neurological Disorders, 2020-2034
• Figure 153. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Cardiovascular Diseases, 2020-2034
• Figure 154. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Rare & Genetic Disorders, 2020-2034
• Figure 155. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Infectious Diseases, 2020-2034
• Figure 156. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Musculoskeletal Disorders, 2020-2034
• Figure 157. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Autoimmune Diseases, 2020-2034
• Figure 158. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Other Applications, 2020-2034
• Figure 159. Middle East & Africa Cell and Gene Therapy Manufacturing Market Analysis, By End-User, 2020, 2024 and 2034
• Figure 160. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By End-User
• Figure 161. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2020-2034
• Figure 162. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Contract Development & Manufacturing Organizations (CDMOs/CMOs), 2020-2034
• Figure 163. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Research Institutes & Academic Organizations, 2020-2034
• Figure 164. Middle East & Africa Cell and Gene Therapy Manufacturing Market (US$ Mn), by Hospitals & Clinics, 2020-2034
• Figure 165. Middle East & Africa Cell and Gene Therapy Manufacturing Market Analysis, By Country, 2020, 2024 and 2034
• Figure 166. Middle East & Africa Cell and Gene Therapy Manufacturing Market Attractiveness Analysis, By Country